DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
Subscribe To Our Newsletter & Stay Updated